Cargando…
Influence of GAS5/MicroRNA‐223‐3p/P2Y12 Axis on Clopidogrel Response in Coronary Artery Disease
BACKGROUND: Dual antiplatelet therapy based on aspirin and P2Y12 receptor antagonists such as clopidogrel is currently the primary treatment for coronary artery disease (CAD). However, a percentage of patients exhibit clopidogrel resistance, in which genetic factors play vital roles. This study aime...
Autores principales: | Liu, Yan‐Ling, Hu, Xiao‐Lei, Song, Pei‐Yuan, Li, He, Li, Mu‐Peng, Du, Yin‐Xiao, Li, Mo‐Yun, Ma, Qi‐Lin, Peng, Li‐Ming, Song, Ming‐Yu, Chen, Xiao‐Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751826/ https://www.ncbi.nlm.nih.gov/pubmed/34713722 http://dx.doi.org/10.1161/JAHA.121.021129 |
Ejemplares similares
-
CD80 DNA methylation and single-nucleotide polymorphism associated with clopidogrel response: a whole-genome DNA methylation analysis in acute coronary syndrome
por: Song, Pei-Yuan, et al.
Publicado: (2023) -
Association of N6AMT1 rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery Disease
por: Li, He, et al.
Publicado: (2018) -
Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease
por: Zhang, Yan-Jiao, et al.
Publicado: (2022) -
P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Chen, Po-Wei, et al.
Publicado: (2020) -
lncRNA GAS5 promotes pyroptosis in COPD by functioning as a ceRNA to regulate the miR-223-3p/NLRP3 axis
por: Mo, Rubing, et al.
Publicado: (2022)